News Shanghai Xuerong Biotechnology Co.,Ltd.

Equities

300511

CNE100002706

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
3.45 ^CNY	+1.77%		+8.15%	-35.51%

Apr. 25	Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Shanghai Xuerong Biotechnology Co.,Ltd. Approves Board Appointments	23-08-24	CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Shanghai Xuerong Biotechnology Co.,Ltd. Approves By-Election of Directors	22-05-30	CI
Shanghai Xuerong Biotechnology Co.,Ltd. Announces Final Cash Dividend Proposal for 2021	22-04-27	CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Shanghai Xuerong Biotechnology Co.,Ltd. announced that it has received CNY 397.999996 million in funding	22-03-14	CI
Yinwan Huayi No. 1 Private Securities Investment Fund managed by Zhejiang Invest Equity Investment & Management Co., Ltd. agreed to acquire 5% stake in Shanghai Xuerong Biotechnology Co.,Ltd. from Yang Yongping for CNY134 million.	21-11-15	CI
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-29	CI
Shanghai Xuerong Biotechnology Co.,Ltd. Announces to Implement Final Cash Distribution Plan for 2020, Payable on 14 May 2021	21-05-11	CI
Shanghai Xuerong Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2020	21-05-06	CI
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Shanghai Xuerong Biotechnology Co., Ltd. Announces Final Cash Dividend for the Year 2020	21-04-12	CI
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-09	CI
Shanghai Juhui Biopharmaceutical Industrial Development Co., Ltd. entered into a share transfer agreement to acquire Shanghai Gaorong Biotechnology Co., Ltd. from Shanghai Xuerong Biotechnology Co., Ltd. and Shanghai Xuerong Edible Fungus Co., Ltd for CNY 78 million.	20-12-30	CI
Shanghai Xuerong Biotechnology Co., Ltd. announced that it expects to receive CNY 2.25 billion in funding	20-10-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Shanghai Xuerong Biotechnology Co.,Ltd.

Equities

300511

CNE100002706

Summary

Filters